Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

524 public trials 99 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Recruiting

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

NCT06463665

Conditions: Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Bronchial Neoplasms, +23 more
Locations: Pioneer Research Center, LLC Bullhead City, Arizona, United States

Clermont Oncology Center Clermont, Florida, United States

Oncology & Hematology Associates of West Broward Coral Springs, Florida, United States

Helios Clinical Research Fort Lauderdale, Florida, United States

View all 15 locations

View Trial Details

Recruiting

Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

NCT03370406

Conditions: Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +3 more
Locations: St. Margaret Hospital Dermatology Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma

NCT06833229

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations: Centre Antoine Lacassagne Nice, France

View Trial Details

Recruiting

A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

NCT05977998

Conditions: Carcinoma, Carcinomatosis, Gastric Adenocarcinoma, +3 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

NCT04897321

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +65 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

NCT05541016

Conditions: Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +16 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

NCT06997068

Conditions: Carcinoma, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Cancer, +34 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

NCT06380816

Conditions: Adnexal Diseases, Advanced Solid Tumours, Breast Diseases, +53 more
Locations: Guy's Hopsital London, United Kingdom

The Christie NHS Foundation Trust Manchester, United Kingdom

The Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom

University Hospital Southampton NHS Foundation Trust Southampton, United Kingdom

View Trial Details

Recruiting

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

NCT06564623

Conditions: Biliary Tract Cancers, Biliary Tract Diseases, Biliary Tract Neoplasms, +8 more
Locations: SKCCC Johns Hopkins Medical Institution Baltimore, Maryland, United States

View Trial Details

Recruiting

Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer

NCT06205836

Conditions: Adenocarcinoma, Carcinoma, Colonic Diseases, +13 more
Locations: Johns Hopkins SKCCC Baltimore, Maryland, United States

View Trial Details